Ritholtz Wealth Management Dr Reddys Laboratories LTD Transaction History

Ritholtz Wealth Management

$3.28 Billion
Q3 2024

A detailed history of Ritholtz Wealth Management transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Ritholtz Wealth Management holds 17,415 shares of RDY stock, worth $267,668. This represents 0.04% of its overall portfolio holdings.

Number of Shares

17,415

Previous 15,847 9.89%

Holding current value

$267,668

Previous $1.21 Million 14.58%

% of portfolio

0.04%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$75.41 - $84.21 $118,242 - $132,041	1,568 Added 9.89%	17,415 $1.38 Million
Q2 2024 Jul 31, 2024	BUY	$68.26 - $76.19 $3,208 - $3,580	47 Added 0.3%	15,847 $1.21 Million
Q1 2024 Apr 24, 2024	BUY	$67.36 - $77.59 $136,269 - $156,964	2,023 Added 14.68%	15,800 $1.16 Million
Q4 2023 Jan 18, 2024	BUY	$64.27 - $69.9 $210,612 - $229,062	3,277 Added 31.21%	13,777 $958,000
Q3 2023 Oct 13, 2023	BUY	$61.9 - $72.77 $216,835 - $254,913	3,503 Added 50.06%	10,500 $702,000
Q2 2023 Jul 14, 2023	BUY	$53.34 - $63.11 $53,980 - $63,867	1,012 Added 16.91%	6,997 $441,000
Q1 2023 Apr 19, 2023	BUY	$51.63 - $56.93 $59,684 - $65,811	1,156 Added 23.94%	5,985 $340,000
Q4 2022 Jan 18, 2023	BUY	$51.15 - $57.45 $37,953 - $42,627	742 Added 18.16%	4,829 $0
Q3 2022 Oct 18, 2022	SELL	$49.9 - $57.32 $1,397 - $1,604	-28 Reduced 0.68%	4,087 $214,000
Q2 2022 Jul 15, 2022	SELL	$49.62 - $58.13 $36,966 - $43,306	-745 Reduced 15.33%	4,115 $228,000
Q1 2022 Apr 14, 2022	SELL	$48.27 - $65.25 $369,555 - $499,554	-7,656 Reduced 61.17%	4,860 $271,000
Q4 2021 Jan 18, 2022	SELL	$59.5 - $67.25 $147,679 - $166,914	-2,482 Reduced 16.55%	12,516 $819,000
Q3 2021 Oct 14, 2021	SELL	$60.19 - $75.29 $284,518 - $355,895	-4,727 Reduced 23.96%	14,998 $977,000
Q2 2021 Jul 20, 2021	BUY	$62.12 - $74.2 $289,727 - $346,068	4,664 Added 30.97%	19,725 $1.45 Million
Q1 2021 May 12, 2021	BUY	$57.98 - $73.08 $40,875 - $51,521	705 Added 4.91%	15,061 $925,000
Q4 2020 Jan 19, 2021	BUY	$62.61 - $71.29 $81,142 - $92,391	1,296 Added 9.92%	14,356 $1.02 Million
Q3 2020 Oct 23, 2020	BUY	$51.39 - $72.41 $159,925 - $225,339	3,112 Added 31.28%	13,060 $908,000
Q2 2020 Jul 15, 2020	BUY	$39.55 - $54.65 $393,443 - $543,658	9,948 New	9,948 $527,000

Others Institutions Holding RDY

# of Institutions

245

Shares Held

23.1M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.55B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.

Account

Ritholtz Wealth Management Dr Reddys Laboratories LTD Transaction History